161 related articles for article (PubMed ID: 33247685)
1. Significance of Some Non-Invasive Biomarkers in the Early Diagnosis and Staging of Egyptian Breast Cancer Patients.
Motawi TM; Zakhary NI; Darwish HA; Abdullah H; Tadros SA
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3279-3284. PubMed ID: 33247685
[TBL] [Abstract][Full Text] [Related]
2. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
3. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
4. Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis.
Ilhan TT; Kebapcilar A; Yilmaz SA; Ilhan T; Kerimoglu OS; Pekin AT; Akyurek F; Unlu A; Celik C
Asian Pac J Cancer Prev; 2015; 16(11):4503-8. PubMed ID: 26107194
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
Assiri AM; Kamel HF
Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
[TBL] [Abstract][Full Text] [Related]
6. Assay of serum CEACAM1 as a potential biomarker for breast cancer.
Yang C; He P; Liu Y; He Y; Yang C; Du Y; Zhou M; Wang W; Zhang G; Wu M; Gao F
Clin Chim Acta; 2015 Oct; 450():277-81. PubMed ID: 26343926
[TBL] [Abstract][Full Text] [Related]
7. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Matsuda T; Fujita S; Kato K; Hamaguchi T; Shimada Y
Cancer Sci; 2010 May; 101(5):1286-91. PubMed ID: 20331631
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
[TBL] [Abstract][Full Text] [Related]
9. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
[TBL] [Abstract][Full Text] [Related]
10. Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression.
Syrbe U; Callhoff J; Conrad K; Poddubnyy D; Haibel H; Junker S; Frommer KW; Müller-Ladner U; Neumann E; Sieper J
Arthritis Rheumatol; 2015 Mar; 67(3):678-85. PubMed ID: 25417763
[TBL] [Abstract][Full Text] [Related]
11. Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
Motawi TMK; Zakhary NI; Darwish HA; Abdalla HM; Tadros SA
Clin Breast Cancer; 2019 Apr; 19(2):e276-e282. PubMed ID: 30765238
[TBL] [Abstract][Full Text] [Related]
12. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
[TBL] [Abstract][Full Text] [Related]
13. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Gotoda T; Katai H; Kato K; Hamaguchi T; Shimada Y
J Gastroenterol; 2009; 44(7):685-90. PubMed ID: 19430715
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of visfatin, resistin and pro-inflammatory cytokine interleukin-8 in acute pancreatitis.
Daniel P; Leśniowski B; Mokrowiecka A; Jasińska A; Pietruczuk M; Małecka-Panas E
Pancreatology; 2010; 10(4):477-82. PubMed ID: 20720449
[TBL] [Abstract][Full Text] [Related]
15. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis.
Fioravanti A; Giannitti C; Cheleschi S; Simpatico A; Pascarelli NA; Galeazzi M
Int J Biometeorol; 2015 Nov; 59(11):1691-700. PubMed ID: 25750093
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa.
González-López MA; Vilanova I; Ocejo-Viñals G; Arlegui R; Navarro I; Guiral S; Mata C; Pérez-Paredes MG; Portilla V; Corrales A; González-Vela MC; González-Gay MA; Blanco R; Hernández JL
Arch Dermatol Res; 2020 Oct; 312(8):595-600. PubMed ID: 31786710
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
19. Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases.
Motawi TM; Shaker OG; El-Sawalhi MM; Abdel-Nasser ZM
Genome; 2014 May; 57(5):259-66. PubMed ID: 25120107
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
